CompletedNCT00320047
Baclofen for binge eating and food cravings
About this title
Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder
Read the official source — NCT00320047Medication studyAges 18–55United StatesEating disorders
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- New YorkSee all locations and recruitment
Study information
Study start dateApril 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00320047
- Official title
Show the full official title
Effects of Baclofen on Binge Eating in Bulimia Nervosa and Binge Eating Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Baclofen.
Who was this study for?
Listed age limits: 18 years to 55 years.
